# Filing Detail

Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-020775
Filing Date
2021-01-28
Accepted
2021-01-28 16:11:31
Documents
7

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B5 | d260304d424b5.htm | 424B5 | 736445
2 | GRAPHIC | g260304g00a00.jpg | GRAPHIC | 25970
3 | GRAPHIC | g260304g10g27.jpg | GRAPHIC | 99747
4 | GRAPHIC | g260304g29d49.jpg | GRAPHIC | 117466
5 | GRAPHIC | g260304g47o32.jpg | GRAPHIC | 31047
6 | GRAPHIC | g260304g96y01.jpg | GRAPHIC | 276515
7 | GRAPHIC | g260304g99a99.jpg | GRAPHIC | 28633
| Complete submission text file | 0001193125-21-020775.txt |  | 1536276

Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-228970 | Film No.: 21565074
SIC: 2834 Pharmaceutical Preparations